CLINICAL-DIAGNOSTIC ASSESSMENT OF PATIENTS WITH OVARIAN CANCER

Kamyshov S. V.*

ABSTRACT

The aim of the study was to assess the clinical and diagnostic characteristics of patients with ovarian cancer who were recommended to accompany immunopharmacotherapy. According to the ultrasound examination, a tumor of more than 10 cm was detected in 143 (54.8%) patients and up to 10 cm in 118 (45.2%) patients. One-sided lesion was observed in 113 (43.3%) of them and bilateral - in 148 (56.7%) patients. The abdominal dissemination was absent in 107 (41.0%) patients, it had insignificant sizes - in 91 (34.9) and up to 2 cm - in 63 (24.1%) patients. The presence of ascitic fluid in the abdominal cavity was absent in 145 (55.6%) patients, up to 2 liters were determined in 65 (24.9%) and more than 2 liters in 51 (19.5%) patients. Tumor cells in ascites or flushing of the abdominal cavity were found in 73 (62.9%) patients and absent in 43 (37.1%) of 116 patients with ascites. When the EIPHT methods were assigned to patients with OC, the results of clinico-diagnostic studies were taken into account in the greatest extent. Anamnestic data, the presence of specific antitumor or nontraditional types of treatment before admission to hospital, histological type of tumor, macroscopic form of growth and the extent of its prevalence were taken into account. As is customary, EIPHT methods were designed, first of all, to reduce toxic manifestations after chemotherapy and radiation therapy, as well as to improve the overall condition after extensive surgery in patients with oncogynecological diseases.

Keywords: ovarian cancer, polychemotherapy, immunotherapy, 5-year survival, morphological features of the tumor.